A phase I study of continuous-infusion soluble CD4 as a single agent and in combination with oral dideoxyinosine therapy in children with symptomatic human immunodeficiency virus infection. J Pediatr Husson RN, Chung Y, Mordenti J, Butler KM, Chen S, Duliege A-M, Brouwers P, Jarosinski P, Mueller BU, Ammann A, Pizzo PA 1992; 121: 627-33